Effect of GABA on ADHD and Seizures in Children With Epilepsy.
NCT ID: NCT04144439
Last Updated: 2019-10-30
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
PHASE4
30 participants
INTERVENTIONAL
2018-07-01
2028-12-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Ketamine and Levetiracetam as Second-line Antiseizure Medication for Status Epilepticus in Children
NCT07046611
Efficacy of Levetiracetam in Control of Neonatal Seizures Guided by an EEG
NCT03107507
Seizure Prevention in Traumatic Brain Injury With Levetiracetam and Lacosamide
NCT06866691
Cognitive Effects of Treatment of Interictal Discharges
NCT00916149
Effectiveness of Combined Levetiracetam and Midazolam in Generalized Convulsive Status Epilepticus in Children
NCT04926844
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
SINGLE_GROUP
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Before treatment
no intervention
No interventions assigned to this group
After treatment
GABA
GABA
Gamma amino butyric acid
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
GABA
Gamma amino butyric acid
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* ADHD
Exclusion Criteria
4 Years
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Sherief Abd-Elsalam
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Sherief Abd-Elsalam
Ass. Prof. Tropical Medicine
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Abeer Salamah, Lecturer
Role: PRINCIPAL_INVESTIGATOR
Lecturer of Pediatrics - Kafr Elsheikh University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Sherief Abd-Elsalam
Tanta, , Egypt
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Abeer Salamah, Msc
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
GABA
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.